Real World Comparison of Rivaroxaban and Warfarin in Korean Patients with Atrial Fibrillation: Propensity Matching Cohort Analysis

Rivaroxaban has emerged as a potential alternative to warfarin for the prevention of thromboembolism in patients with atrial fibrillation (AF). However, there has been concern for the risk of major bleeding, especially in Asian patients. We investigated the efficacy and safety of rivaroxaban compare...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Chonnam Med J
Päätekijät: Jeong, Hyung Ki, Lee, Ki Hong, Park, Hyung Wook, Yoon, Nam Sik, Kim, Min Chul, Lee, Nuri, Kim, Ji Sung, Ahn, Youngkeun, Jeong, Myung Ho, Park, Jong Chun, Cho, Jeong Gwan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Chonnam National University Medical School 2019
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6351319/
https://ncbi.nlm.nih.gov/pubmed/30740341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4068/cmj.2019.55.1.54
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia